Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Trop Med Hyg ; 104(5): 1851-1857, 2021 03 08.
Artigo em Inglês | MEDLINE | ID: mdl-33684066

RESUMO

The price of certain antiparasitic drugs (e.g., albendazole and mebendazole) has dramatically increased since 2010. The effect of these rising prices on treatment costs and use of standard of care (SOC) drugs is unknown. To measure the impact of drug prices on overall outpatient cost and quality of care, we identified outpatient visits associated with ascariasis, hookworm, and trichuriasis infections from the 2010 to 2017 MarketScan Commercial Claims and Encounters and Multi-state Medicaid databases using Truven Health MarketScan Treatment Pathways. Evaluation was limited to members with continuous enrollment in non-capitated plans 30 days prior, and 90 days following, the first diagnosis. The utilization of SOC prescriptions was considered a marker for quality of care. The impact of drug price on the outpatient expenses was measured by comparing the changes in drug and nondrug outpatient payments per patient through Welch's two sample t-tests. The total outpatient payments per patient (drug and nondrug), for the three parasitic infections, increased between 2010 and 2017. The increase was driven primarily by prescription drug payments, which increased 20.6-137.0 times, as compared with nondrug outpatient payments, which increased 0.3-2.2 times. As prices of mebendazole and albendazole increased, a shift to alternative SOC and non-SOC drug utilization was observed. Using parasitic infection treatment as a model, increases in prescription drug prices can act as the primary driver of increasing outpatient care costs. Simultaneously, there was a shift to alternative SOC, but also to non-SOC drug treatment, suggesting a decrease in quality of care.


Assuntos
Albendazol/economia , Anti-Helmínticos/economia , Ascaríase/economia , Infecções por Uncinaria/economia , Ivermectina/economia , Mebendazol/economia , Tricuríase/economia , Albendazol/uso terapêutico , Animais , Anti-Helmínticos/uso terapêutico , Ascaríase/diagnóstico , Ascaríase/tratamento farmacológico , Ascaríase/parasitologia , Custos de Medicamentos/tendências , Gastos em Saúde/estatística & dados numéricos , Infecções por Uncinaria/diagnóstico , Infecções por Uncinaria/tratamento farmacológico , Infecções por Uncinaria/parasitologia , Humanos , Ivermectina/uso terapêutico , Mebendazol/uso terapêutico , Pacientes Ambulatoriais , Solo/parasitologia , Padrão de Cuidado/tendências , Tricuríase/diagnóstico , Tricuríase/tratamento farmacológico , Tricuríase/parasitologia , Estados Unidos
2.
Trop Med Int Health ; 6(6): 449-57, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11422959

RESUMO

We conducted a randomized clinical intervention trial over 24 weeks on a tea estate in north-east Bangladesh to investigate the effect of iron supplementation and anthelmintic treatment on the labour productivity of adult female tea pluckers. A total of 553 full-time tea pluckers, not pregnant and not breastfeeding, were randomly assigned to one of the four intervention groups: group 1 received iron supplementation on a weekly basis, group 2 received anthelmintic treatment at the beginning and half-way through the trial (week 12), group 3 received both iron supplementation as group 1 and anthelmintic treatment as group 2, and group 4 was a control group and received placebos. No significant difference in labour productivity was found between the four intervention groups over the trial period. However, there was a negative association for all three worms (Ascaris lumbricoides, Trichuris trichiura and hookworms) between the intensity of helminth infections (eggs/g faeces) and all measures of labour productivity. Lower haemoglobin values and anaemia (< 120 g/l Hb) were both associated with lower labour productivity and more days sick and absent. Taller women with greater arm circumference were able to pluck more green leaves, earn higher wages and were absent less often.


Assuntos
Anemia Ferropriva/tratamento farmacológico , Anti-Helmínticos/uso terapêutico , Eficiência , Compostos Ferrosos/uso terapêutico , Helmintíase/tratamento farmacológico , Adolescente , Adulto , Idoso , Agricultura , Albendazol/uso terapêutico , Anemia Ferropriva/economia , Anemia Ferropriva/parasitologia , Ascaríase/complicações , Ascaríase/tratamento farmacológico , Ascaríase/economia , Bangladesh/epidemiologia , Suplementos Nutricionais , Quimioterapia Combinada , Feminino , Ácido Fólico/uso terapêutico , Helmintíase/complicações , Helmintíase/economia , Infecções por Uncinaria/complicações , Infecções por Uncinaria/tratamento farmacológico , Infecções por Uncinaria/economia , Humanos , Renda , Pessoa de Meia-Idade , Estado Nutricional , Licença Médica/estatística & dados numéricos , Chá , Tricuríase/complicações , Tricuríase/tratamento farmacológico , Tricuríase/economia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA